INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 118 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,892,000 | +253.0% | 553,300 | +37.4% | 0.00% | – |
Q2 2016 | $536,000 | -79.7% | 402,625 | -19.5% | 0.00% | -100.0% |
Q1 2016 | $2,636,000 | -32.9% | 500,092 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $3,926,000 | -7.1% | 500,092 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $4,226,000 | +21.4% | 500,092 | +57.2% | 0.00% | 0.0% |
Q2 2015 | $3,482,000 | -13.6% | 318,079 | +10.3% | 0.00% | 0.0% |
Q1 2015 | $4,032,000 | -2.9% | 288,379 | +17.3% | 0.00% | 0.0% |
Q4 2014 | $4,154,000 | -9.8% | 245,918 | -28.4% | 0.00% | 0.0% |
Q3 2014 | $4,607,000 | -47.3% | 343,291 | -50.0% | 0.00% | 0.0% |
Q2 2014 | $8,748,000 | +114.3% | 686,582 | +100.0% | 0.00% | 0.0% |
Q1 2014 | $4,082,000 | -13.9% | 343,291 | 0.0% | 0.00% | -33.3% |
Q4 2013 | $4,741,000 | -20.9% | 343,291 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $5,990,000 | +51.5% | 343,291 | +41.1% | 0.00% | +50.0% |
Q2 2013 | $3,954,000 | +181.2% | 243,328 | +739.0% | 0.00% | +100.0% |
Q1 2013 | $1,406,000 | – | 29,002 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |